Autografting of bone marrow mesenchymal stem cells alleviates streptozotocin-induced diabetes in miniature pigs: Real-time tracing with MRI in vivo

Cellular replacement therapy for diabetes mellitus (DM) has received much attention. In this study, we investigated the effect of transplantation of autologous bone marrow-derived mesenchymal stem cells (ABMSCs) in streptozotocin (STZ)-induced diabetic miniature pigs. Miniature pig BMSCs were cultured, labeled with superparamagnetic iron oxide (SPIO) and transplanted into the pancreas of diabetic miniature pigs through targeted intervention. Blood glucose levels, intravenous and oral glucose tolerance test (OGTT), serum insulin, C-peptide and islets histology were analyzed. These transplanted cells were then identified by magnetic resonance imaging (MRI). The results showed that transplantation of ABMSCs reversed STZ-induced diabetes in miniature pigs. Blood glucose levels, intravenous, OGTT, serum insulin and C-peptide were significantly recovered in the diabetic minipigs with the autologous BMSC (DMAB) transplantation group. In addition, the number of islets was significantly increased in this group compared to the diabetic minipig control (DMC) group with conventional therapy. These data suggested the implantation of autologous BMSCs for type 1 diabetes treatment can partially restore the function of islet β cells and maintain blood glucose homeostasis. Transplanted autologous BMSCs may improve islet repairing by differentiating for new islets and change pancreatic microcirculation and be identified in a real-time manner using MRI in vivo.

[1]  J. Li,et al.  Tracing type 1 diabetic Tibet miniature pig's bone marrow mesenchymal stem cells in vitro by magnetic resonance imaging (1型糖尿病西藏小型猪骨髓间充质干细胞体外磁共振成像示踪) , 2014, Journal of diabetes.

[2]  B. Prabhakar,et al.  Reversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cells , 2012, BMC Medicine.

[3]  M. Foss,et al.  Stem cell therapy for diabetes mellitus , 2011, Kidney international supplements.

[4]  R. Mahfouz,et al.  Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: A pilot study , 2010, Journal of Neuroimmunology.

[5]  M. Atkinson,et al.  Congenic Mesenchymal Stem Cell Therapy Reverses Hyperglycemia in Experimental Type 1 Diabetes , 2010, Diabetes.

[6]  M. Foss,et al.  Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. , 2009, JAMA.

[7]  M. Foss,et al.  C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. , 2009, JAMA.

[8]  Y. Yoon,et al.  Dual Angiogenic and Neurotrophic Effects of Bone Marrow–Derived Endothelial Progenitor Cells on Diabetic Neuropathy , 2009, Circulation.

[9]  C. Bailey,et al.  Sustained insulin secretory response in human islets co-cultured with pancreatic duct-derived epithelial cells within a rotational cell culture system , 2009, Diabetologia.

[10]  Y. Oiso,et al.  Transplantation of Bone Marrow–Derived Mesenchymal Stem Cells Improves Diabetic Polyneuropathy in Rats , 2008, Diabetes.

[11]  Yong Liu,et al.  Reversal of new-onset type 1 diabetes in mice by syngeneic bone marrow transplantation. , 2008, Biochemical and biophysical research communications.

[12]  X. Qin,et al.  Transplantation of bone marrow derived cells promotes pancreatic islet repair in diabetic mice. , 2008, Biochemical and biophysical research communications.

[13]  F. Ezquer,et al.  Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[14]  Clive Wasserfall,et al.  Autologous umbilical cord blood infusion for type 1 diabetes. , 2008, Experimental hematology.

[15]  F. Jakob,et al.  Beta-cell replacement and regeneration: Strategies of cell-based therapy for type 1 diabetes mellitus. , 2008, Diabetes research and clinical practice.

[16]  N. Scolding,et al.  Autologous mesenchymal bone marrow stem cells: Practical considerations , 2008, Journal of the Neurological Sciences.

[17]  M. Neri,et al.  Efficient In Vitro Labeling of Human Neural Precursor Cells with Superparamagnetic Iron Oxide Particles: Relevance for In Vivo Cell Tracking , 2008, Stem cells.

[18]  H. Tai,et al.  Safe Induction of Diabetes by High-Dose Streptozotocin in Pigs , 2008, Pancreas.

[19]  J. Voltarelli,et al.  Autologous stem cell transplantation for early type 1 diabetes mellitus , 2008, Autoimmunity.

[20]  E. Gócza,et al.  Mesenchymal Stem Cells Cooperate with Bone Marrow Cells in Therapy of Diabetes , 2008, Stem cells.

[21]  J. Leor,et al.  Iron-Oxide Labeling and Outcome of Transplanted Mesenchymal Stem Cells in the Infarcted Myocardium , 2007, Circulation.

[22]  D. Melton,et al.  Recovery from diabetes in mice by β cell regeneration , 2007 .

[23]  Matthias Stuber,et al.  Magnetic resonance–guided, real-time targeted delivery and imaging of magnetocapsules immunoprotecting pancreatic islet cells , 2007, Nature Medicine.

[24]  H. Nakauchi,et al.  Bone marrow (BM) transplantation promotes beta-cell regeneration after acute injury through BM cell mobilization. , 2007, Endocrinology.

[25]  Darwin J. Prockop,et al.  Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice , 2006, Proceedings of the National Academy of Sciences.

[26]  G. Korbutt,et al.  Reversal of diabetes in pancreatectomized pigs after transplantation of neonatal porcine islets. , 2005, Diabetes.

[27]  Peter Girman,et al.  MRI of transplanted pancreatic islets , 2004, Magnetic resonance in medicine.

[28]  B. Burkhardt,et al.  In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow. , 2004, Diabetes.

[29]  Jeff W M Bulte,et al.  Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. , 2003, Radiology.

[30]  R. Carr,et al.  Mild streptozotocin diabetes in the Göttingen minipig. A novel model of moderate insulin deficiency and diabetes. , 2002, American journal of physiology. Endocrinology and metabolism.

[31]  Y. Zhang,et al.  Mesenchymal stroma cells improve hyperglycemia and insulin deficiency in the diabetic porcine pancreatic microenvironment. , 2008, Cytotherapy.

[32]  D. Melton,et al.  Recovery from diabetes in mice by beta cell regeneration. , 2007, The Journal of clinical investigation.

[33]  A. Bean,et al.  Development of an anti-porcine CD34 monoclonal antibody that identifies hematopoietic stem cells. , 2007, Experimental hematology.

[34]  M. Lipsett,et al.  Islet neogenesis: a potential therapeutic tool in type 1 diabetes. , 2006, The international journal of biochemistry & cell biology.

[35]  P. Cuevas,et al.  A new approach for bone marrow‐derived stem cells intrapancreatic autotransplantation in diabetic rats , 2006, Microsurgery.

[36]  R. Carr,et al.  Measurements of insulin secretory capacity and glucose tolerance to predict pancreatic beta-cell mass in vivo in the nicotinamide/streptozotocin Göttingen minipig, a model of moderate insulin deficiency and diabetes. , 2003, Diabetes.

[37]  M. Hussain,et al.  In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. , 2003, The Journal of clinical investigation.